Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06612970
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-23
Brief Title:
A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1a Randomized Double-blind Placebo-controlled Single Dose-escalation Study to Evaluate the Safety Tolerability and Pharmacokinetics of HB0056 in Adult Healthy Subjects
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to investigate the safety and tolerability of HB0056 in healthy subjects following single-dose
Detailed Description:
This is a single-dose escalation study of HB0056 to evaluate the safety tolerability pharmacokinetics and immunogenicity of HB0056
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None